MedPath

A clinical trial to study the effect of the drug lekhaniya mahakashaya on patients of obesity(hyperlipidemia)

Phase 3
Not yet recruiting
Conditions
Patient of sthaulya (Hyperlipidemia)
Registration Number
CTRI/2018/02/011874
Lead Sponsor
Ch brahm prakash ayurved charak sansthan khera dabar najafgargh
Brief Summary

Obesity is a prevalent nutritional disorder in which energy intake exceeds the energy output over a sufficiently long period of time and energy stores of the body remain too large, although the genetic component  to obesity remains a possibility, it is unlikely to be great or to prevent weight loss being possible in most patient by reducing energy intake. environmental influences are believed to be more important in explaining the familial association in obesity.An inactive lifestyle is thought to play a role in the development of obesity.

**Drugs-**Lekhaniya mahakashaya

**Dose-** 48 gm BD with luke warm water

**Study type**-Interventional

**Study time-**18 Months

**Interventional time**-40 Days

**Sample size**-20 Patient in each group

**Group1**- Lekhaniya mahakashaya kwath

**Group2-** pathya ahar vihar and yoga asan and exerscise

**Assessment criteria-**

**Subjective criteria-** chal sphik, utsaha hani,ksudra swas,atinidra,swedadhikya,anga daurgandhya,anga gauravata,ati pipasa,ati ksuda

**Objective criteria-** chest, abdomen, hip, mid thigh,  mid arm, BMI range (kg/m2)

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • The well diagnostic pt.of sthaulya (Hyperlipidemia)will be selected s.cholesterol->200mg/dl s.
  • triglyceride- > 150mg/dl s.LDL- >110 S.VLDL-> 40mg/dl.
Exclusion Criteria
  • suffering with any systemic disease like cardiac and renal disease hypertention.
  • pt suffering for endocrine disorder like diabetes thyroid dysfunction etc.
  • pregnant females and lactating females.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1.Reduce symptoms of obesity and relief of symtoms18 month
like atinidra,chala sphik,utsaha hani,kshudra shawas anga daurgandhya etc18 month
Secondary Outcome Measures
NameTimeMethod
1.aetiopathogenesis of sthaulya will be assessed by adopting suitable subjective parameters.2.Decrease elevated level of s.cholesterol s.triglyceride s. LDL S.VLDL Etc.

Trial Locations

Locations (1)

Ch brahm prakash ayurved charak sansthan khera dabar najafgarh 73

🇮🇳

Delhi, DELHI, India

Ch brahm prakash ayurved charak sansthan khera dabar najafgarh 73
🇮🇳Delhi, DELHI, India
Prof Dr Vidula Gujjarwar
Principal investigator
9990174348
shreemahalaxmi1969@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.